Healthscope Limited [ASX:HSO] have been offered a $4.1 billion payout from private equity firm BGH Capital Fund.
The proposal came in the wake of Healthscope’s huge 14.78% increase in share value, which took place earlier today.
Healthscope’s directors are currently discussing the proposal, while assessing possible outcomes and a proper course of action.
As a healthcare services company that operates across Australia and many other countries across the pacific, Healthscope Limited provides various types of medical
services to thousands of patients.
Their shares are now valued at $2.33.
How Healthscope are approaching the takeover offer
Healthscope have stated that they don’t need to take any action regarding the proposal at this time, and that the transaction is far from complete.
If the deal took place, that means Healthscope would return to a private equity platform.
In The Australian Financial Review, Healthscope stated:
‘The Healthscope board has commenced an assessment of the proposal and will keep the market informed of any material developments in accordance with its continuous disclosure requirements.’
The offer comes with the requirement that Healthscope does not sell any of its assets at this stage, which includes its Asian pathology business that Healthscope were looking to sell recently.
Healthscope are required to go through a number of conditions to fully put the deal in place before the proposal is validated. For example, shareholders must vote in favour of the transition for it to be in effect.
Australian Super already owns a small portion of Healthscope, so the take-over comes with familiarity.
For Money Morning
PS: If you want to lay down a little money on the hottest corner of the ASX right now�but you don�t know your way around the small-cap sector�this report is for you. Get access now (free).